[Stepwise therapy of allergic rhinosinusitis].
After examination of 240 patients with allergic rhinosinusitis (ARS) of whom 60 had edematose ARS and 60 edematose ARS associated with bronchial asthma (BA) treated unsuccessfully with topic glucocorticosteroids the patients received intranasal diprospan by an original scheme. Sixty patients with an initial stage of polypous ARS and associated ENT pathology and 60 ARS patients with hypertrophic mucosa of the middle and/or lower nasal cavities and unfavourable variants of intranasal anatomy were operated (functional endonasal interventions). A retrospective analysis of the efficacy of the therapeutic-diagnostic algorithm of treatment policy showed that 92% patients benefited from the above treatment.
Kriukov
A I
AI
Gurbanov
F A
FA
D000465:Algorithms; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004338:Drug Combinations; D004724:Endoscopy; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy* / Q000601:surgery*
D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; C032812:betamethasone dipropionate, betamethasone sodium phosphate drug combination; D001623:Betamethasone